Surrozen, Inc.
A biotechnology company that discovers and develops biological drug candidates that selectively regulate the Wnt pathway, which is essential for tissue repair in various organs and tissues. The company is developing drugs for ulcerative colitis and inflammatory bowel disease, as well as alcoholic hepatitis. The company is based in Delaware.
Overview
Overview | |
|---|---|
Country | United States |
State | California |
Employees | 42 |
Founded | 2015 |
Financials | |
|---|---|
Market Capitalization | 29.52M |
Revenue | |
Operating Income | -40.32M |
Operating Margin | |
Net Income | -37.58M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4331 / 5373 |
Sector : Healthcare | 665 / 1144 |
Industry : Biotechnology | 294 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 4789 / 5565 |
Sector : Healthcare | 898 / 1182 |
Industry : Biotechnology | 497 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4173 / 5436 |
Sector : Healthcare | 643 / 1164 |
Industry : Biotechnology | 293 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4520 / 5330 |
Sector : Healthcare | 836 / 1174 |
Industry : Biotechnology | 397 / 667 |